The Potential Clinical and Economic Benefits of a Next Generation Omicron-Containing (BA.1) Bivalent Sars-Cov-2 Booster Compared to First Generation Prototype Boosters in Germany Assuming BA.4/BA.5 Dominance

Maschio, M.; Schweikert, B.; Ultsch, B.; Cai, R.; Fust, K.; Lee, A.; Nasir, A.; Buck, P.; Van de Velde, N.; Kohli, M.

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

The Potential Clinical and Economic Benefits of a Next Generation Omicron-Containing (BA.1) Bivalent Sars-Cov-2 Booster Compared to First Generation Prototype Boosters in Germany Assuming BA.4/BA.5 Dominance

Maschio, M.; Schweikert, B.; Ultsch, B.; Cai, R.; Fust, K.; Lee, A.; Nasir, A.; Buck, P.; Van de Velde, N.; Kohli, M..

Value Health ; 25(12):S68-9, 2022.

Article in English | PubMed Central | ID: covidwho-2159385

Fulltext

Print

XML

Search on Google

Full text: Available Collection: Databases of international organizations Database: PubMed Central Type of study: Prognostic study Topics: Vaccines / Variants Language: English Journal: Value Health Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

Print

XML

Search on Google

Full text: Available Collection: Databases of international organizations Database: PubMed Central Type of study: Prognostic study Topics: Vaccines / Variants Language: English Journal: Value Health Year: 2022 Document Type: Article